Search Results - "Shuangni Yu"

Refine Results
  1. 1

    Expression of the immune checkpoint VISTA in breast cancer by Zong, Liju, Mo, Shengwei, Yu, Shuangni, Zhou, Yuncan, Zhang, Ming, Chen, Jie, Xiang, Yang

    Published in Cancer Immunology, Immunotherapy (01-08-2020)
    “…V-domain Ig suppressor of T cell activation (VISTA) is a novel immune checkpoint that is an emerging target for cancer immunotherapy. This study aimed to…”
    Get full text
    Journal Article
  2. 2

    Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer by Zong, Liju, Mo, Shengwei, Sun, Zezheng, Lu, Zhaohui, Yu, Shuangni, Chen, Jie, Xiang, Yang

    Published in Modern pathology (01-02-2022)
    “…V-domain Ig-containing suppressor of T-cell activation (VISTA) is a novel immune checkpoint protein and a potential immunotherapeutic target. However, its…”
    Get full text
    Journal Article
  3. 3

    miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2 by Ma, Yihui, Yu, Shuangni, Zhao, Wugan, Lu, Zhaohui, Chen, Jie

    Published in Cancer letters (08-12-2010)
    “…Abstract MicroRNAs are short regulatory RNAs. A growing body of data implicates altered miRNA participate in the development of cancers and miR-27a is…”
    Get full text
    Journal Article
  4. 4

    miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer by Yu, Shuangni, Lu, Zhaohui, Liu, Changzheng, Meng, Yunxiao, Ma, Yihui, Zhao, Wugan, Liu, Jianping, Yu, Jia, Chen, Jie

    Published in Cancer research (Chicago, Ill.) (15-07-2010)
    “…Therapeutic applications of microRNA (miRNA) in KRAS-driven pancreatic cancers might be valuable, but few studies have explored this area. Here, we report that…”
    Get full text
    Journal Article
  5. 5

    Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma by Chen, Xianlong, Ma, Heng, Mo, Shengwei, Yu, Shuangni, Lu, Zhaohui, Chen, Jie

    Published in Frontiers in immunology (17-10-2022)
    “…Extracellular traps (ETs) and tumor-infiltrating immune cells play crucial roles in tumor progression. However, little is known about the clinical significance…”
    Get full text
    Journal Article
  6. 6

    Loss of ARID1A Expression Correlates With Tumor Differentiation and Tumor Progression Stage in Pancreatic Ductal Adenocarcinoma by Zhang, Li, Wang, Cuiping, Yu, Shuangni, Jia, Congwei, Yan, Jie, Lu, Zhaohui, Chen, Jie

    Published in Technology in cancer research & treatment (01-01-2018)
    “…Mutations in the AT-rich interactive domain 1A gene, which encodes a subunit of the Switch/Sucrose nonfermentable chromatin remodeling complex, can result in…”
    Get full text
    Journal Article
  7. 7

    MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2 by Sun, Yang, Zhang, Tingting, Wang, Cuiping, Jin, Xianglan, Jia, Congwei, Yu, Shuangni, Chen, Jie

    Published in PloS one (09-04-2015)
    “…Aberrant microRNA (miRNA) expression is associated with tumor development. This study aimed to elucidate the role of miR-615-5p in the development of…”
    Get full text
    Journal Article
  8. 8

    Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma by Zhou, Na, Tang, Hui, Yu, Shuangni, Lin, Yi, Wang, Yingyi, Wang, Yuzhou

    Published in Frontiers in immunology (06-12-2022)
    “…Pulmonary lymphoepithelioma-like carcinoma (LELC) exhibits a unique immune microenvironment, including high PD-L1 expression and abundant infiltrating-immune…”
    Get full text
    Journal Article
  9. 9

    MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma by Liu, Changzheng, Yu, Jia, Yu, Shuangni, Lavker, Robert M, Cai, Lei, Liu, Wei, Yang, Kegong, He, Xiaodong, Chen, Songsen

    Published in Journal of hepatology (01-07-2010)
    “…Background & Aims MicroRNA-21 negatively regulates several targets, thereby affecting tumorigenesis. However, its mechanism of action in human hepatocellular…”
    Get full text
    Journal Article
  10. 10

    Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma by Chen, Xianlong, Ma, Heng, Mo, Shengwei, Zhang, Yue, Lu, Zhaohui, Yu, Shuangni, Chen, Jie

    Published in Frontiers in immunology (22-07-2022)
    “…Immune checkpoint modulation has been a vital therapeutic option in many malignancies, and targeting of novel immune checkpoints, including OX40/OX40L…”
    Get full text
    Journal Article
  11. 11

    Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia by Cheng, Hongyan, Zong, Liju, Yu, Shuangni, Chen, Jie, Wan, Xirun, Xiang, Yang, Yang, Junjun

    Published in Pathology oncology research (16-02-2023)
    “…To evaluate the expression of emerging immune targets in the tumor-infiltrating immunocytes (TIIs) of human gestational trophoblastic neoplasia (GTN)…”
    Get full text
    Journal Article
  12. 12

    Deregulation of the MiR-193b-KRAS Axis Contributes to Impaired Cell Growth in Pancreatic Cancer by Jin, Xianglan, Sun, Yang, Yang, Haiyan, Li, Ji, Yu, Shuangni, Chang, Xiaoyan, Lu, Zhaohui, Chen, Jie

    Published in PloS one (23-04-2015)
    “…Modulation of KRAS activity by upstream signals has revealed a promising new approach for pancreatic cancer therapy; however, it is not clear whether…”
    Get full text
    Journal Article
  13. 13

    Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications by Ban, Xinchao, Mo, Shengwei, Lu, Zhaohui, Jia, Congwei, Shao, Huilin, Chang, Xiaoyan, Mao, Xinxin, Zhang, Yue, Pang, Junyi, Zhang, Yuhan, Yu, Shuangni, Chen, Jie

    Published in Endocrine (01-09-2022)
    “…Purpose Recent studies claim that immune checkpoint inhibitors are effective in defective mismatch repair (dMMR) cancers. This raises the question of whether…”
    Get full text
    Journal Article
  14. 14

    Genetic Alteration Profiles and Clinicopathological Associations in Atypical Parathyroid Adenoma by Mao, Xinxin, Wu, Yan, Yu, Shuangni, Chen, Jie

    Published in International journal of genomics (2021)
    “…Genomic aberrations associated with atypical parathyroid adenoma (AA) are poorly understood. Thus, herein, we sought to expand our current understanding of the…”
    Get full text
    Journal Article
  15. 15

    Correction to: Expression of the immune checkpoint VISTA in breast cancer by Zong, Liju, Mo, Shengwei, Yu, Shuangni, Zhou, Yuncan, Zhang, Ming, Chen, Jie, Xiang, Yang

    Published in Cancer Immunology, Immunotherapy (01-08-2020)
    “…The original version of this article unfortunately contained a mistake. The correct information is given below…”
    Get full text
    Journal Article
  16. 16

    Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study by Yu, Shuangni, Sun, Zezheng, Zong, Liju, Yan, Jie, Yu, Mei, Chen, Jie, Lu, Zhaohui

    Published in Journal of gynecologic oncology (01-05-2022)
    “…The molecular classification system of endometrial carcinoma (EC) in 'The Cancer Genome Atlas' is widely acknowledged for its prognostic utility. Subsequently,…”
    Get full text
    Journal Article
  17. 17

    Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix by Xiang, Yang, Chen, Jie, Yu, Shuangni, Kong, Yujia, Zhou, Yuncan, Zhang, Qianqian, Zong, Liju, Zhang, Youzhong

    Published in Journal of immunology research (2020)
    “…The purpose of this study was to investigate the expression levels of the immune checkpoint proteins, programmed cell death-ligand 1 (PD-L1), B7-H3, B7-H4, and…”
    Get full text
    Journal Article
  18. 18

    Ezrin promotes invasion and metastasis of pancreatic cancer cells by Meng, Yunxiao, Lu, Zhaohui, Yu, Shuangni, Zhang, Qiang, Ma, Yihui, Chen, Jie

    Published in Journal of translational medicine (23-06-2010)
    “…Pancreatic cancer has a high mortality rate because it is usually diagnosed when metastasis have already occurred (microscopic and gross disease). Ezrin plays…”
    Get full text
    Journal Article
  19. 19

    Detection of POLE Subtypes in High-Grade Endometrioid Carcinoma by BaseScope-ISH Assay by Yu, Shuangni, Shao, Huilin, Ban, Xinchao, Zhang, Hongkai, You, Yan, Zhou, Na, Mao, Xinxin, Zhao, He, Chen, Jie, Lu, Zhaohui

    Published in Frontiers in oncology (04-09-2019)
    “…Objective: The identification of DNA polymerase epsilon (POLE) mutation subtypes in endometrial cancer is critical for molecular classification. The mutation…”
    Get full text
    Journal Article
  20. 20

    Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma by Chen, Xianlong, Mo, Shengwei, Zhang, Yue, Ma, Heng, Lu, Zhaohui, Yu, Shuangni, Chen, Jie

    “…Siglec‐15, a novel immune checkpoint, is an emerging target for next‐generation cancer immunotherapy. However, the role of Siglec‐15 in pancreatic ductal…”
    Get full text
    Journal Article